Cellectis S.A. (CMVLF)
OTCMKTS
· Delayed Price · Currency is USD
1.250
0.00 (0.00%)
At close: May 22, 2025
Cellectis Revenue
Cellectis had revenue of $12.03M in the quarter ending March 31, 2025, with 85.10% growth. This brings the company's revenue in the last twelve months to $54.75M, up 351.26% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.
Revenue (ttm)
54.75M
Revenue Growth
+351.26%
P/S Ratio
2.04
Revenue / Employee
249.99K
Employees
222
Market Cap
111.54M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49.22M | 40.02M | 435.37% |
Dec 31, 2023 | 9.19M | -16.53M | -64.26% |
Dec 31, 2022 | 25.72M | -12.87M | -33.35% |
Dec 31, 2021 | 38.60M | -20.97M | -35.20% |
Dec 31, 2020 | 59.56M | 36.57M | 159.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Cellectis News
- 9 days ago - Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 - GlobeNewsWire
- 15 days ago - Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy - Seeking Alpha
- 18 days ago - Cellectis Non-GAAP EPS of -$0.17, revenue of $12M misses by $1.83M - Seeking Alpha
- 18 days ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire
- 21 days ago - Cellectis Q1 2025 Earnings Preview - Seeking Alpha
- 24 days ago - Cellectis to Report First Quarter Financial Results on May 12, 2025 - GlobeNewsWire
- 4 weeks ago - Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting - GlobeNewsWire
- 2 months ago - Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript - Seeking Alpha